Study of BHV-4157 in Alzheimer's Disease

Clinical trial NCT03605667 · COMPLETED

Trial details

NCT number: NCT03605667
Sponsor: Biohaven Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2018-07-31
Primary completion: 2020-12-15
Enrollment: 350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.